What are the next steps for a patient with bilateral pleural effusions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bilateral Pleural Effusions

For a patient with bilateral pleural effusions on ultrasound, the first step is to determine whether the effusion is likely a transudate or exudate through clinical assessment, and if the clinical picture does not strongly suggest a transudate, proceed with diagnostic thoracentesis to guide further management. 1, 2

Initial Evaluation

Clinical Assessment

  • Evaluate for clinical features suggesting transudative effusions:
    • Heart failure (most common cause of bilateral effusions)
    • Hypoalbuminemia
    • Renal failure requiring dialysis
    • Liver cirrhosis

Important Considerations

  • Do not perform thoracentesis if the clinical picture strongly suggests a transudate (e.g., clear heart failure) unless there are atypical features or failure to respond to therapy 1
  • Take a detailed drug history as medications can cause exudative pleural effusions 1, 2
  • Consider pulmonary embolism if patient has pleuritic pain and dyspnea out of proportion to effusion size 1

Diagnostic Algorithm

Step 1: Clinical Assessment and Imaging

  • Review ultrasound findings for:
    • Size of effusions
    • Presence of loculations or septations
    • Pleural thickening or masses

Step 2: Determine Need for Thoracentesis

  • If clinical picture strongly suggests transudate → Treat underlying cause
  • If clinical picture unclear or suggests exudate → Proceed with thoracentesis

Step 3: Diagnostic Thoracentesis

  • Perform ultrasound-guided thoracentesis using a fine bore (21G) needle and 50ml syringe 1, 2
  • Send samples in both sterile vials and blood culture bottles for:
    • Protein and LDH (to differentiate transudate from exudate)
    • pH (especially if infection suspected)
    • Glucose
    • Cell count with differential
    • Gram stain and culture
    • Cytology for malignant cells
    • AAFB stain and TB culture if tuberculosis suspected 1

Interpretation and Management

If Transudate (meets Light's criteria):

  • Most commonly due to heart failure, cirrhosis, or hypoalbuminemia
  • Treat the underlying cause (e.g., diuretics like furosemide for heart failure) 3
  • Monitor response to treatment

If Exudate:

  • Further investigation based on pleural fluid analysis:
    • Malignancy: Consider CT scan of thorax (with contrast) with fluid present for better visualization of pleura 1, 2
    • Infection: If pH < 7.2 or purulent fluid, consider chest tube drainage 2
    • Tuberculosis: Send for AAFB stain and TB culture
    • Chylothorax: Check triglyceride levels if milky fluid

If Diagnosis Remains Unclear:

  • Refer to chest physician 1
  • Consider contrast-enhanced CT thorax
  • Consider pleural biopsy (ultrasound/CT guided, closed pleural biopsy, or thoracoscopy)

Common Pitfalls to Avoid

  • Performing thoracentesis on bilateral effusions when clinical picture strongly suggests transudate (e.g., clear heart failure) 1, 2
  • Failing to consider pulmonary embolism as a cause of exudative effusion 1
  • Not recognizing that bilateral effusions often have multiple etiologies (83% have two or more causes) 4
  • Overlooking malignancy as a common cause of exudative bilateral effusions 4
  • Delaying drainage in complicated parapneumonic effusions or empyema 2

Special Considerations During COVID-19

  • In patients with suspected or confirmed COVID-19, pleural effusion is uncommon (5.3-5.8% of cases) 1
  • When performing pleural procedures in COVID-19 patients:
    • Use full personal protective equipment
    • Perform procedures in a negative pressure room if available
    • Use trained staff to minimize procedure duration and complications 1

Remember that the prognosis for patients with exudative pleural effusions depends on the underlying cause, with malignant effusions carrying a poorer prognosis (median survival 3-12 months) 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Exudative Pleural Effusions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Etiologies of bilateral pleural effusions.

Respiratory medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.